Adjuvant perioperative portal vein or peripheral intravenous chemotherapy for potentially curative colorectal cancer: long-term results of a randomized controlled trial

[1] Pisani P(1993)Estimates of the worldwide mortality from eighteen major cancers in 1985. Implications for prevention and projections of future burden Int J Cancer 55 891-903

[2] Parkin DM(1985)Colorectal Carcinoma: a survey of 1345 cases 1950–1984 Acta Chir Scand 151 675-679

[3] Ferlay J(1988)Adjuvant therapy of colorectal cancer. Why we still don’t know J Am Med Assoc 259 3571-3578

[4] Oldham U(1957)The prophylactic treatment of cancer at the time of operation Ann Surg 146 588-593

[5] Buyse M(1979)Adjuvant cytotoxic liver perfusion for colorectal cancer Br J Surg 66 833-837

[6] Zeleniuch-Jacquotte A(1995)Long-term results of single course of adjuvant intraportal chemotherapy for colorectal cancer Lancet 345 349-353

[7] Chalmers TC(1980)Percutaneous hepatic arterial infusion (HAI) of mitomycin C and floxuridine (FUDR): an effective treatment for metastatic colorectal carcinoma in the liver Cancer 46 261-265

[8] Morales F(1990)Adjuvant therapy for resectable colorectal carcinoma with fluorouracil administered by portal vein infusion. A study of the Mayo Clinic and the North Central Cancer Treatment Group Arch Surg 125 897-901

[9] Bell M(1992)Randomised controlled trial of adjuvant chemotherapy by portal-vein perfusion after curative resection for colorectal adenocarcinoma Lancet 340 502-506

[10] McDonald GO(1990)Adjuvant portal liver infusion in colorectal cancer with 5-fluorouracil/heparin versus urokinase versus control. Results of a prospective randomized clinical trial (colorectal adenocarcinoma trial I) Cancer 65 425-432

[1] Pisani P(1993)Estimates of the worldwide mortality from eighteen major cancers in 1985. Implications for prevention and projections of future burden Int J Cancer 55 891-903

[2] Parkin DM(1985)Colorectal Carcinoma: a survey of 1345 cases 1950–1984 Acta Chir Scand 151 675-679

[3] Ferlay J(1988)Adjuvant therapy of colorectal cancer. Why we still don’t know J Am Med Assoc 259 3571-3578

[4] Oldham U(1957)The prophylactic treatment of cancer at the time of operation Ann Surg 146 588-593

[5] Buyse M(1979)Adjuvant cytotoxic liver perfusion for colorectal cancer Br J Surg 66 833-837

[6] Zeleniuch-Jacquotte A(1995)Long-term results of single course of adjuvant intraportal chemotherapy for colorectal cancer Lancet 345 349-353

[7] Chalmers TC(1980)Percutaneous hepatic arterial infusion (HAI) of mitomycin C and floxuridine (FUDR): an effective treatment for metastatic colorectal carcinoma in the liver Cancer 46 261-265

[8] Morales F(1990)Adjuvant therapy for resectable colorectal carcinoma with fluorouracil administered by portal vein infusion. A study of the Mayo Clinic and the North Central Cancer Treatment Group Arch Surg 125 897-901

[9] Bell M(1992)Randomised controlled trial of adjuvant chemotherapy by portal-vein perfusion after curative resection for colorectal adenocarcinoma Lancet 340 502-506

[10] McDonald GO(1990)Adjuvant portal liver infusion in colorectal cancer with 5-fluorouracil/heparin versus urokinase versus control. Results of a prospective randomized clinical trial (colorectal adenocarcinoma trial I) Cancer 65 425-432